Cassava Sciences, Inc. is a company in the U.S. stock market and it is a holding in 37 U.S.-traded ETFs....
sava stock forecast 2025
We are a clinical-stage biopharmaceutical company focused on neuroscience. We translate novel scientific insights into new medicines. Similarly, Why is...
Stock Price Forecast The 5 analysts offering 12-month price forecasts for Cassava Sciences Inc have a median target of 110.00,...
Much of this rise can be attributed to its investigational drug – Simufilam – for the treatment of Alzheimer’s disease...
